tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
US Market
NKTR
Nektar Therapeutics
RESEARCH TOOLSreports
Want to see NKTR full AI Analyst Report?

Nektar Therapeutics (NKTR) Income Statement

1,611 Followers

Nektar Therapeutics Income Statement

Last quarter (Q4 2025), Nektar Therapeutics's total revenue was $21.81M, a decrease of -25.25% from the same quarter last year. In Q4, Nektar Therapeutics's net income was $-36.08M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 55.23M$ 98.43M$ 90.12M$ 92.06M$ 101.91M
Gross Profit
$ 55.23M$ 67.74M$ 53.48M$ 70.42M$ 77.01M
Operating Expenses
$ 186.00M$ 172.94M$ 190.90M$ 310.66M$ 523.11M
Depreciation and Amortization
$ 1.03M$ 4.39M$ 7.82M$ 12.20M$ 14.15M
EBITDA
$ -129.74M$ -86.70M$ -243.11M$ -323.87M$ -461.82M
Operating Income
$ -130.77M$ -105.20M$ -137.43M$ -240.24M$ -446.10M
Other Income/Expenses
$ -33.44M$ -14.00M$ -138.83M$ -124.75M$ -77.18M
Pretax Income
$ -164.21M$ -119.20M$ -276.26M$ -364.98M$ -523.28M
Net Income
$ -164.08M$ -118.96M$ -276.06M$ -368.20M$ -523.84M
Per Share Metrics
Basic EPS
$ -9.73$ -8.68$ -21.79$ -29.51$ -42.90
Diluted EPS
$ -9.73$ -8.68$ -21.79$ -29.51$ -42.90
Weighted Average Shares Outstanding
 16.87M 13.71M 12.67M 12.48M 12.22M
Weighted Average Shares Outstanding (Diluted)
 16.87M 13.71M 12.67M 12.48M 12.22M
Currency in USD

Nektar Therapeutics Earnings and Revenue History